Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feedergoogle.co.in
Google Alert - evommune
Get the latest updates from Google Alert - evommune directly as they happen.
Follow now 114 followers
Latest posts
Last updated 18 days ago
듀피젠트, 10년 만에 CSU 새 치료제로 승인… 美 FDA 적응증 확대 - 팜뉴스
19 days ago
Celldex·Evommune 등 경쟁사도 개발 가속… 면역질환 치료 시장 재편 조짐. 사노피 듀피젠트...
에이프릴바이오 "APB-R3 아토피 이어 MASH에도 효능" - 이데일리
19 days ago
임상 1상을 마치고 지난해 6월 미국의 자가염증질환 치료제개발 전문 바이오텍 에보뮨(Evommune)에 약...
San Francisco Business Times on X: "Evommune launches mid-stage trials for immune ...
23 days ago
Evommune launches mid-stage trials for immune-modulating drugs targeting skin conditions, backed by...
Evommune launches 2nd mid-stage clinical trial in skin condition - San Francisco Business Times
23 days ago
"Chronic autoimmune diseases will limit your lifespan," Evommune CEO Peña said. "It...
Daily Derm Times: April 15, 2025
24 days ago
Evommune has initiated a global phase 2b trial of EVO756, a first-in-class...
First Patient Enrolled in Evommune's Phase 2b Trial of an MRGPRX2 Antagonist in CSU
24 days ago
The first patient has been enrolled in a global Phase 2b trial...
Evommune Advances EVO756 Into Global Phase 2b Trial for Chronic Spontaneous Urticaria
24 days ago
Evommune has initiated a global phase 2b trial of EVO756, a first-in-class...
Evommune Initiates Phase 2b Trial of MRGPRX2 Antagonist, EVO756, in Adults with ...
25 days ago
Evommune, Inc. is a clinical-stage biotechnology company discovering and developing new ways...
Evommune Initiates Phase 2b Trial of MRGPRX2 Antagonist, EVO756, in Adults with ...
25 days ago
Evommune, Inc., a clinical stage biotechnology company discovering and developing new ways...
Chronic Inflammation Therapy Market: Innovations Driving - openPR.com
about 1 month ago
... Evommune, Inc., Sterna biologicals, Halia Therapeutics, Inc., Amgen Inc. - published...
We are excited to announce enrollment of the first patient in a Phase 2… | Evommune - LinkedIn
about 2 months ago
We are excited to announce enrollment of the first patient in a...
에이프릴바이오, APB-R3 아토피 2상 환자 투여 개시 - 히트뉴스
about 2 months ago
회사는 기술이전 파트너사인 미국 에보뮨(Evommune)이 현지 시간으로 17일 'APB-R3'의 현지 코드명 'EVO301'을...